Class-wide concerns: Cancer risk (GH/IGF-1 promote cell proliferation), glucose metabolism effects, fluid retention, joint/connective tissue effects
As mentioned earlier, inositol could also support neurotransmitter signaling
The near-term catalyst it is carrying into the week is a first-half 2026 phase 2/3 readout for ABL001 (tovecimig) in second-line biliary tract cancer
In addition, its crucial to attend ongoing follow-up appointments with your provider so they can monitor your response to the medication and adjust your treatment plan as necessary
These reduce appetite, help control blood sugar, and support steady weight loss under medical supervision
To understand how semaglutide could fit into your personal health plan, we encourage you to take our free assessment quiz